연구동향 분석
박사

Anti-allergic inflammatory effects of probiotics in RAW264.7 macrophages and atopic dermatitis animal models

현진이 2020년

논문상세정보
    • 저자 현진이
    • 기타서명 RAW264.7 대식세포와 아토피 피부염 동물 모델에서 프로바이오틱스의 항알러지 염증반응에 미치는 영향
    • 형태사항 v, 70장: 삽화, 도표: 26 cm
    • 일반주기 국문, 영문초록 수록, 지도교수: 최인순, 참고문헌 수록
    • 학위논문사항 바이오과학과(생물학전공), 2020. 2, 학위논문(박사)-, 신라대학교 일반대학원
    • KDC 5, 475.352
    • 발행지 부산
    • 언어 kor
    • 출판년 2020
    • 발행사항 신라대학교 일반대학원
    • 주제어 바이오과학과 생물학 아토피 피부염
    유사주제 논문( 39)
인용/피인용
' Anti-allergic inflammatory effects of probiotics in RAW264.7 macrophages and atopic dermatitis animal models' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 미생물학
  • 바이오과학과
  • 생물학
  • 아토피
  • 피부염
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
43 0

0.0%

' Anti-allergic inflammatory effects of probiotics in RAW264.7 macrophages and atopic dermatitis animal models' 의 참고문헌

  • Williams R. E. and Hafler D. A. , IL-12 induces human T cells secreting IL-10 with IFN-gamma
    157 , 1127-1131 ( [1996]
  • Weiner H. L. and Kuchroo V. K. , Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
    441 , 235-238 ( [2006]
  • Watkins S. K. and Suttles J. , Macrophages Sequentially Change Their Functional Phenotype in Response to Changes in Microenvironmental Influences
    175 , 342-349 [2005]
  • Tranilast directly targets NLRP3 to treat inflammasome-driven diseases
    10 , e8689 ( [2018]
  • Therapeutic effects of kefir grain Lactobacillus-derived extracellular vesicles in mice with 2,4,6-trinitrobenzene sulfonic acid-induced inflammatory bowel disease
    101 , 8662-8671 [2018]
  • Therapeutic Effect of Rumex japonicus Houtt . on DNCB-Induced Atopic Dermatitis-Like Skin Lesions in Balb/c Mice and Human Keratinocyte HaCaT Cells
    7 , e573 ( [2019]
  • The role of mast cells in allergic inflammation
    106 , 9-14 [2012]
  • The Impact of Food Bioactives on Health
    [2015]
  • Schreiber R. D. and Stark G. R. , Stat1-dependent and – independent pathways in IFN-γ-dependent signaling
    23 , 96-101 ( [2002]
  • Schmidt-Arras D. and Rose-John S. The proand antiinflammatory properties of theCytokine interleukin-6 ,
    1813 , 878- 888 ( [2011]
  • Sanjabi S. , Robertson A. K. and Flavell R. A. , Transforming growth factor-beta regulation of immune responses
    24 , 99-146 ( [2006]
  • STAT1 mediates oroxylin a inhibition of iNOS and pro-inflammatory cytokines expression in microglial BV-2 cells
    7 , e50363 ( [2012]
  • S. W. andChoi H. J. , WeissellaCibaria WIKIM28 ameliorates atopic dermatitis-like skin lesions by inducing tolerogenic dendriticCells
    BALB/c mice , Sci
  • S. J. , Asthma prevention by Lactobacillus Rhamnosus in a mouse model is Associated withCD4 +CD25 +Foxp3
    . Res. , 4
  • Role of IL-10 in host response against infection of Salmonella typhimurium
    [2010]
  • Putignani L. and E Hachem M. , Gut microbiota profile inChildren affected by atopic dermatitis and evaluation of intestinal persistence of a probiotic mixture
    9 , e4996 [2019]
  • Probiotics modulate the gut microbiotaComposition and immune responses in patients with atopic dermatitis : a pilot study
    58 , 1-12 [2019]
  • Patja A. and Peltola H. , Measles history and atopic diseases : a population-based cross-sectional study
    283 , 343-346 ( [2000]
  • Oral administration of Lactobacillus plantarum CJLP133 and CJLP243 alleviates birch pollen induced allergic rhinitis in mice
    124 , 821-828 [2018]
  • OShea J. J. and Koyasu S. , IFN-γ production by antigen-presenting cells : mechanisms emerge
    22 , 556-560 ( [2001]
  • Nowicki R. J. and Trzeciak M. , New cytokines in the pathogenesis of atopic dermatitis-new therapeutic targets
    19 , e3086 [2018]
  • NF-κB regulation in the immune system
    2 , 725-734 ( [2002]
  • Morsaljahan Z. and Haj-Ghorbani S. T. , Effect of ginger extract on expression of GATA3 , T-bet and ROR-γt in peripheral blood mononuclear cells of patients with Allergic Asthma
    47 , 378-385 ( [2019]
  • Mau J. L. and Pan T. M. , Immunomodulatory effects of dead Lactobacillus on murine splenocytes and macrophages
    23 , 183-202 [2012]
  • Macrophage polarization and infection , J. Bacteriol
    44 , 290-295 ( [2014]
  • Lindsey M. L. and IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation
    112 , 33 ( [2017]
  • Life P. and Bonnefoy J. Y. , IL-12 synergizes with IL2 and other stimuli in inducing IL-10 production by human T cells
    [1996]
  • Kusumowidagdo E. R. and Surono I. S. , Lactobacillus plantarum IS10506 supplementation reduced SCORAD in children with atopic dermatitis
    Microbes , 8 , 833-840 ( [2017]
  • Koskinen P. and Isolauri E. , Probiotics in primary prevention of atopic disease : a randomised placebo-controlled trial
    357 , 1076-1079 [2001]
  • Interleukin-10-deficient mice develop chronic enterocolitis
    75 , 263-274 ( [1993]
  • Interleukin-10 : new perspectives on an old cytokine
    226 , 205-218 [2008]
  • Interleukin 2 plays a central role in Th2 differentiation ,
    101 , 3880-3885 ( [2004]
  • Inhibitory effects of Aristotelia chilensis water extract on 2,4-Dinitrochlorobenzene induced atopic-like dermatitis in BALB/c Mice
    DOI 10.12932/AP-190418-0298 ( 2019 ) .
  • Inhibitory effect of naringin on lipopolysaccharide ( LPS ) -induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages
    78 , 673-681 [2006]
  • Inhibitory effect of Psidium guajava water extract in the development of 2,4-dinitrochlorobenzene-induced atopic dermatitis in NC/Nga mice
    50 , 2923-2929 ( [2012]
  • Importance of IL-10 modulation by probiotic microorganisms in gastrointestinal inflammatory diseases.
    [2011]
  • Immunostimulatory activity of apios tuber extract on RAW264.7 macrophage cells
    46 , 248-257 ( [2016]
  • Immunomodulatory mast cells : negative , as well as positive , regulators of immunity
    8 , 478-486 ( [2008]
  • IgE reactivity against herpes simplex virus 1 in patients with atopic dermatitis complicated by eczema herpeticum
    25 , 53127 ( [2019]
  • IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses
    156 , 2776-2782 [1996]
  • Hwang K. C. and Im S. H. , Lactobacillus casei potentiates induction of oral tolerance in experimental arthritis
    46 , 172-180 ( [2008]
  • Hwang K. C. and Im S. H. , Generation of regulatory dendritic cells and CD4 +Foxp3 +
    Acad . Sci . [2010]
  • Habu S. and Kaminogawa S. , Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte cultures
    115 , 278-287 ( [1998]
  • Gaston J. E. and Baltimore D. , Achieving stability of lipopolysaccharide-induced NF-κB activation
    309 , 1854-1857 [2005]
  • Exploring the full spectrum of macrophage activation
    8 , 958-969 [2008]
  • Enrica R. and Amilcare C. , Atopic dermatitis : recent insight on pathogenesis and novel therapeutic target
    34 , 98-108 ( [2016]
  • Effects of anti-inflammatory and Rehmanniae radix pharmacopuncture on atopic dermatitis in NC/Nga mice
    6 , 98-109 ( [2013]
  • Effects of Lactobacillus rhamnosus on allergic march model by suppressing Th2 , Th17 , and TSLP responses via CD4 +CD25 +Foxp3 + Tregs ,
    153 , 178-186 ( [2014]
  • David P. M. and Francisco M. C. , Effect of oral administration of a mixture of probiotic strains on SCORAD Index and use of topical
    with moderate atopic
  • Crocin Ameliorates Atopic Dermatitis Symptoms by down Regulation of Th2 Response via Blocking of NF-κB/STAT6 Signaling Pathways in Mice
    10 , e1625 ( [2018]
  • Choi I. S.and Yun C. H. , A Probiotic mixture regulates T cell balance and reduces atopic dermatitis symptoms in mice
    15 , 2414-2422 [2018]
  • Chiara M. and Fian V. Z. , Probiotics and atopic dermatitis in children
    [2012]
  • Chemical constituents and anti-inflammatory activities of Maqian ( Zanthoxylum myriacanthum var . pubescens ) bark extracts
    [2017]
  • C. S. , Che J. H. , Park B. K. and Jung J. Y. , Anti‑inflammatory
    macrophages and DNCB‑induced atopic
  • Brzoska J. and Kreysel H. W. , Systemic interferon gamma treatment in severe atopic dermatitis
    29 , 58-63 ( [1993]
  • Broussonin E suppresses LPS-induced inflammatory response in macrophages via inhibiting MAPK pathway and enhancing JAK2-STAT3 pathway
    17 , 372-380 [2019]
  • Bond M. W. and Mosmann T. R. , Two types of mouse T helper cell . IV . Th2 clones secrete a factor that inhibits cytokine production by Th1 clones
    170 , 2081-2095 ( [1989]
  • Baus D. and Litterst C. M. , The role of STATs in inflammation and inflammatory diseases
    10 , 2839-2850 ( [2004]
  • B. Jr. and Manuel J. C. , The burden of atopic dermatitis : impact on the patient , family , and society
    22 , 192-199 ( [2005]
  • Atopic dermatitis : new insights and opportunities for therapeutic intervention
    105 , 860-876 [2000]
  • Atopic dermatitis : a disease of altered skin barrier and immune dysregulation
    242 , 233-246 ( [2011]
  • Antiinflammatory effect of lactic acid bacteria : inhibition of cyclooxygenase-2 by suppressing nuclear factor-kappaB in Raw264.7 macrophage cells
    18 , 1683-1688 ( [2008]
  • Anti-allergic inflammatory effects of the essential oil from fruits of Zanthoxylum coreanum Nakai
    12 , 1441-1450 ( [2018]
  • Andersen P. S. and Firadin S. E. , Chronic inflammation : importance of NOD2 and NALP3 in interleukin-1β generation
    147 , 227-235 ( [2007]
  • A novel mouse model of atopic dermatitis with epicutaneous allergen sensitization and the effect of Lactobacillus rhamnosus
    21 , 672-675 ( [2012]
  • A Novel Atopic Dermatitis Model Induced by Topical Application with Dermatophagoides Farinae Extract in NC/Nga Mice
    56 , 139-148 ( [2007]
  • 94. Wang Y. H., Voo K. S., Liu B., Chen C. Y., Uygungil B., Spoede W., Bernstein J. A., Huston D. P. and Liu Y. J., A novel subset of CD4 + TH2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma, J. Exp. Med., 207, 2479-2491 (2010).
  • 93. Nakajima S., Kitoh A., Egawa G., Natsuaki Y., Nakamizo S., Moniaga C. S., Otsuka A., Honda T., Hanakawa S., Amano W., Iwakura Y., Nakae S., Kubo M., Miyachi Y. and- 66 - Kabashima K., IL-17A as an inducer for Th2 immune responses in murine atopic dermatitis models, J. Invest. Dermatol., 134, 2122-2130 (2014).
  • 92. Bieber T., Atopic dermatitis, Ann. Dermatol., 22, 125-137 (2010).
  • 91. Erjefalt J. S., Mast cells in human airways: the culprit?, Eur. Respir. Rev., 23, 299-307 (2014).
  • 90. Yamanaka K. I. and Mizutani H., The role of cytokines/chemokines in the pathogenesis of atopic dermatitis, Curr. Probl. Dermatol., 40, 80-92 (2011).
  • 86. Abramovits W., Atopic dermatitis, J. Am. Acad. Dermatol., 53, s86-93 (2005).
  • 85. Doan T., Melvold R., Ciselli S. and Walthenvaugh C., 2014, “Immunology”, 2nd edition, 210-213, Bioscience publisher.
  • 81. Karin M. and Ben-Neriah Y., Phosphorylation meets ubiquitination: the control of NFκB activity, Annu. Rev. Immunol., 18, 621-663 (2000).
  • 80. Rothwarf D. M. and Karin M., The NF-κB activation pathway: a paradigm in information transfer from membrane to nucleus, Sci. STKE., 1999. RE1 (1999).
  • 79. Baeuerle P. A. and Henkel T., Function and activation of NF-κB in the immune system, Annu. Rev. Immunol., 12, 141-179 (1994).
  • 76. Schindler C. and Darnell J. E. Jr., Transcriptional responses to polypeptide ligands: the JAK-STAT pathway, Annu. Rev. Biochem., 64, 621-651 (1995).
  • 71. Couper K. N., Blount D. G. and Riley E. M., IL-10: the master regulator of immunity to infection, J. Immunol., 180, 5771-5777 (2008).
  • 70. Sikka G., Miller K. L., Steppan J., Pandey D., Jung S. M., Fraser C. D., Ellis C., Ross D., Vandegaer K., Bedja D., Gabrielson K., Walston J. D., Berkowitz D. E. and Barouch L. A., Interleukin 10 knockout frail mice develop cardiac and vascular dysfunction with increased age, Exp Gerontol., 48, 128-135 (2013).
  • 67. Chang H. D. and Radbruch A., The pro- and anti-inflammatory potential of interleukin12, Ann. N. Y. Acad. Sci., 1109, 40-46 (2007).
  • 64. Moller B. and Villiger P. M., Inhibition of IL-1, IL-6, and TNF-α in immune-mediated inflammatory diseases, Springer Semin. Immunopathol., 27, 391-408 (2006).
  • 53. Kim J. A., Kim S. H., Kim I. S., Yu D. Y., Kim S. C., Lee S. H., Lee S. S., Yun C. H., Choi I. S. and Cho K. K., Anti-Inflammatory effects of a mixture of lactic acid bacteria and sodium butyrate in atopic dermatitis murine model, J. Med. Food, 21, 716-725 (2018).
  • 50. Berni Canani R., Di Costanzo M., Bedogni G., Amoroso A., Cosenza L., Di Scala C., Granata V. and Nocerino R., Extensively hydrolyzed casein formula containing Lactobacillus rhamnosus GG reduces the occurrence of other allergic manifestations in children with cow's milk allergy: 3-year randomized controlled trial, J. Allergy Clin. Immunol., 139, 1906-1913 (2017).
  • 5. Malbec O. and Daeron M., The mast cell IgG receptors and their roles in tissue inflammation. Immuno. Rev., 217, 206-221 (2007).
  • 45. Guarner F. and Schaafsma G. J., probiotics, Int. J. Food Microbiol., 39, 237-238 (1998).
  • 41. Mombelli B. and Gismondo M. R., The use of probiotics in medical practice, Int. J. Antimicrob. Agents, 16, 531-536 (2000).
  • 40. de Roos N. M. and Katan M. B., Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998, Am. J. Clin. Nutr., 71, 405-411 (2000).
  • 39. Fric P., Probiotics in gastroenterology, Z. Gastroenterol., 40, 197-201 (2002).
    40 , 197-201 [2002]
  • 38. Report of a Joint FAO/WHO Working Group. Guidelines for the Evaluation of Probiotics in Food. London, Ontario, Canada: FAO/WHO (2002).
  • 37. Santosa S., Farnworth E. and Jones P. J., Probiotics and their potential health claims, Nutr. Rev., 64, 265-274 (2006).
  • 35. Kim H. W., Ju D. B., Kye Y. C., Ju Y. J., Kim C. G., Lee I. K., Park S. M., Choi I. S., Cho K. K., Lee S. H., Kim S. C., Jung I. D., Park Y. M., Han S. H. and Yun C. H., Galectin9 induced by dietary probiotic mixture regulates immune cell balance to reduce atopic dermatitis symptoms in mice, forthcoming.
  • 33. Chia B. K. and Tey H. L., Systematic review on the efficacy, safety, and costeffectiveness of topical calcineurin inhibitors in atopic dermatitis, Dermatitis, 26, 122-132 (2015).
  • 32. Tali C., Hames G. K. and Emma G. Y., Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march, J. Allergy Clin. Immunol., 139, 1723-1734 (2017).
  • 29. Papier A. and Strowd L. C., Atopic dermatitis: a review of topical nonsteroid therapy, Drugs Context, 3, 212521-212528 (2018).
  • 28. Galli S. J., Maurer M. and Lantz C. S., Mast cells as sentinels of innate immunity, Curr. Opin. Immunol., 11, 53-59 (1999).
  • 27. Leung D. Y. and Soter N. A., Cellular and immunologic mechanisms in atopic dermatitis, J. Am. Acad. Dermatol., 44, S1-S12 (2001).
  • 26. Silverberg N. B., A practical overview of pediatric atopic dermatitis, part 1: epidemiology and pathogenesis. Cutis, 97, 267-271 (2016).
  • 21. Chang H. D. and Radbruch A., The pro- and anti-inflammatory potential of interleukin12, Ann. N. Y. Acad. Sci., 1109, 40-46 (2007).
  • 19. Moncada S. and Higgs A., The L-arginine-nitric oxide pathway, N. Engl. J. Med., 329, 2002-2012 (1993).
  • 18. Luiking Y. C., Engelen M. P. and Deutz N. E., Regulation of nitric oxide production in health and disease, Curr. Opin. Clin. Nutr. Metab. Care, 13, 97-104 (2010).
  • 16. Biswas S. K. and Mantovani A., Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm, Nat. Immunol., 11, 889-896 (2010).
  • 15. Biswas S. K. and Mantovani A., Orchestration of metabolism by macrophages, Cell Metab., 4, 432-437 (2012).
  • 102. Boyman O., Werfel T. and Akdis C. A., The suppressive role of IL-10 in contact and atopic dermatitis, J. Allergy. Clin. Immunol., 129, 160-161 (2012).
  • 101. Park H. J., Lee S. W. and Hong S., Regulation of allergic immune responses by microbial metabolites, Immune Netw., 18, e15 (2018).
    18 , e15 [2018]
  • 1. Kim Y. J., Choi M. J., Bak D. H., Lee B. C., Ko E. J., Ahn G. R., Ahn S. W., Kim M. J., Na J. and Kim B. J., Topical administration of EGF suppresses immune response and protects skin barrier in DNCB-induced atopic dermatitis in NC/Nga mice, Sci. Rep., 8, 11895-11902 (2018).